Novel Metabolic Disease Therapy

The invention relates to the prevention and treatment of metabolic abnormalities characterized by abnormal glucose metabolism, including diabetes mellitus and new onset diabetes mellitus through the use of fibroblast activation protein (FAP) selective inhibitors.

Patents:
WO 2,010,083,570

Inventor(s): GORRELL MARK [AU]; SONG SUNMI [AU]; WANG XIN [AU]

Type of Offer: Sale